SALUTECH
SaluTech develops a conductive biomaterial (CBM) to treat the underlying cause of the arrhythmia. This CBM has the ability to reduce/diminish arrhythmia while being nontoxic, biocompatible, and inexpensive to produce.
Similar Organizations
Greenbead
Develops an effective biocatalyst technology for laundry detergent
Nature Gluetech
Nature Gluetech develops mass production technology and commercialization technology for bioadhesives.
Investors List
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - SaluTech